A Perspective on Frailty and its Predisposing Factors among People Living with HIV.
Abstract
People Living with HIV (PLHIV) experience accelerated aging, yet strategies for healthy aging in this group are not well studied. Although survival rates have improved, non-infectious comorbidities, like cardiovascular diseases, diabetes, and cancers, are increasing and tend to appear earlier and more severely in PLHIV frailty, defined as increased vulnerability to stressors, which is a growing concern among aging PLHIV, driven by factors, like chronic inflammation, antiretroviral therapy toxicity, and traditional risk factors. Key areas of focus include inactivity, sarcopenia, vitamin D deficiency, and polypharmacy. Addressing these factors is crucial to preventing functional decline and improving the quality of life of PLHIV, though more research is necessary. The aim of this article was to identify and conduct a narrative review of these factors in a pragmatic way in order to facilitate the clinicians.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper addresses frailty and its predisposing factors among people living with HIV, which is relevant to the broader context of aging and age-related diseases. However, it primarily focuses on the symptoms and management of frailty rather than tackling the root causes of aging or proposing innovative strategies for lifespan extension. The findings contribute to understanding the health challenges faced by this population but do not represent a significant advancement in the field of longevity research.
Author of this paper? Send a correction.